PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Feb 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-09

Reporting Person: HENRIKSEN RONALD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-09	Restricted Stock Award	A	1568	—	Acquired	52092	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-09	Employee Stock Option	$6.84	A	25000	Acquired	2020-02-09	Common Stock (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.62	2014-05-12	Common Stock (38500)	38500	Direct

Footnotes

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2010, unless Mr. Henriksen voluntarily resigns prior to 12/31/2010, or if he is nominated, but declines to stand for re-election at the Company's 2010 Annual Meeting. Vesting of the award will be accelerated upon Mr. Henriksen's death or failure to be re-elected at the Company's 2010 Annual Meeting.

F2: The options vest 1/24 each month from date of grant.